标准疗法-话题@MedSci

#标准疗法#

15篇内容 | 948人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2230105, encodeId=21e2223010504, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a> <a href='/topic/show?id=f7e85e929c0' target=_blank style='color:#2F92EE;'>#斑块型银屑病#</a> <a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Front Med：苏州大学儿童医院发表联合生物制剂与标准疗法治疗斑块型银屑病的疗效比较, objectType=article, longId=846353, objectId=2dee8463536e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240719/1721352199808_92910.jpg, objectUrl=/article/show_article.do?id=2dee8463536e, replyNumber=0, likeNumber=111, createdTime=2024-10-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2dee8463536e, moduleTitle=Front Med：苏州大学儿童医院发表联合生物制剂与标准疗法治疗斑块型银屑病的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dee8463536e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2061230, encodeId=39022061230d4, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=J Clin Oncol：Brentuximab Vedotin联合AVD一线治疗早期不良霍奇金淋巴瘤的疗效优于标准疗法, objectType=article, longId=734317, objectId=5093e34317c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5093e34317c1, replyNumber=0, likeNumber=77, createdTime=2022-11-18, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5093e34317c1, moduleTitle=J Clin Oncol：Brentuximab Vedotin联合AVD一线治疗早期不良霍奇金淋巴瘤的疗效优于标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5093e34317c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061228, encodeId=bb9020612287a, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, objectType=article, longId=730182, objectId=b81ce30182de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81ce30182de, replyNumber=0, likeNumber=73, createdTime=2023-05-04, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81ce30182de, moduleTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81ce30182de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061229, encodeId=87c320612292a, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Clin Cancer Res：帕博西尼+氟维司群联合方案或可成为晚期乳腺癌的标准疗法, objectType=article, longId=730360, objectId=9feee303606b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9feee303606b, replyNumber=0, likeNumber=98, createdTime=2023-02-08, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9feee303606b, moduleTitle=Clin Cancer Res：帕博西尼+氟维司群联合方案或可成为晚期乳腺癌的标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9feee303606b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061227, encodeId=0cad206122e3d, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, objectType=article, longId=212904, objectId=f025212904a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f025212904a5, replyNumber=0, likeNumber=80, createdTime=2021-12-11, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f025212904a5, moduleTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f025212904a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061226, encodeId=e83f2061226ab, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Ibrance联合标准疗法治疗乳腺癌：未达到主要终点, objectType=article, longId=195119, objectId=4c951951194a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c951951194a, replyNumber=0, likeNumber=129, createdTime=2021-03-25, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c951951194a, moduleTitle=Ibrance联合标准疗法治疗乳腺癌：未达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c951951194a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061225, encodeId=04bb206122514, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=PACIFIC方案已是III期不可切除非小细胞肺癌的标准疗法, objectType=article, longId=168273, objectId=368a1682e321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=368a1682e321, replyNumber=0, likeNumber=79, createdTime=2019-10-31, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=368a1682e321, moduleTitle=PACIFIC方案已是III期不可切除非小细胞肺癌的标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=368a1682e321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061224, encodeId=4657206122495, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Gastroenterology：OTSC金属内镜夹治疗复发性上消化道出血效果优于标准疗法, objectType=article, longId=139378, objectId=06b41393e838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06b41393e838, replyNumber=0, likeNumber=0, createdTime=2019-05-05, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06b41393e838, moduleTitle=Gastroenterology：OTSC金属内镜夹治疗复发性上消化道出血效果优于标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06b41393e838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061223, encodeId=cd7e2061223b0, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Ann Oncol：依诺肝素联合标准疗法能否改善小细胞肺癌患者的总生存率？, objectType=article, longId=133693, objectId=6a82133693db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a82133693db, replyNumber=0, likeNumber=71, createdTime=2018-12-29, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a82133693db, moduleTitle=Ann Oncol：依诺肝素联合标准疗法能否改善小细胞肺癌患者的总生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a82133693db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061221, encodeId=5e6c206122156, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=ANN ONCOL：CRLX101联合贝伐单抗与标准疗法比较治疗晚期肾细胞癌, objectType=article, longId=121165, objectId=9a2a12116540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2a12116540, replyNumber=0, likeNumber=83, createdTime=2018-01-11, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2a12116540, moduleTitle=ANN ONCOL：CRLX101联合贝伐单抗与标准疗法比较治疗晚期肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2a12116540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061222, encodeId=a8ed2061222ea, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Lancet Oncol：新辅助化疗联合辅助达拉菲尼和曲美替尼对比标准疗法治疗高危型、可手术切除的黑色素瘤的效果。, objectType=article, longId=126919, objectId=c97a126919c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97a126919c3, replyNumber=0, likeNumber=48, createdTime=2018-02-25, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97a126919c3, moduleTitle=Lancet Oncol：新辅助化疗联合辅助达拉菲尼和曲美替尼对比标准疗法治疗高危型、可手术切除的黑色素瘤的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c97a126919c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061219, encodeId=78a72061219f4, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=ASCO：abiraterone与前列腺癌标准疗法联用，存活率可提高40%, objectType=article, longId=100681, objectId=56d41006816f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56d41006816f, replyNumber=0, likeNumber=85, createdTime=2017-07-05, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56d41006816f, moduleTitle=ASCO：abiraterone与前列腺癌标准疗法联用，存活率可提高40%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56d41006816f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061220, encodeId=66ba2061220ff, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=Neovii：临床研究长期结果有力支持Grafalon(R)成为标准疗法, objectType=article, longId=103939, objectId=67e6103939a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e6103939a4, replyNumber=0, likeNumber=74, createdTime=2018-04-19, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e6103939a4, moduleTitle=Neovii：临床研究长期结果有力支持Grafalon(R)成为标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e6103939a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061218, encodeId=bdfd206121826, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=PNAS：维生素C或可增加AML标准疗法的疗效, objectType=article, longId=76398, objectId=1a29e639859, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a29e639859, replyNumber=0, likeNumber=97, createdTime=2017-03-07, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a29e639859, moduleTitle=PNAS：维生素C或可增加AML标准疗法的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a29e639859)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061217, encodeId=f266206121e34, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=NEJM：新型银屑病药物的治疗效率优于当前标准疗法, objectType=article, longId=53173, objectId=0484531e3f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0484531e3f9, replyNumber=0, likeNumber=72, createdTime=2016-01-24, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0484531e3f9, moduleTitle=NEJM：新型银屑病药物的治疗效率优于当前标准疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0484531e3f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2061216, encodeId=9c67206121682, content=<a href='/topic/show?id=f29e6193947' target=_blank style='color:#2F92EE;'>#标准疗法#</a>, objectTitle=JAMA：循证的标准疗法是降压治疗的关键, objectType=article, longId=29724, objectId=298129e24a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=298129e24a8, replyNumber=0, likeNumber=79, createdTime=2014-01-29, rootId=0, userName=feather78, userId=3679417, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=298129e24a8, moduleTitle=JAMA：循证的标准疗法是降压治疗的关键, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=298129e24a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

标准疗法

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#生物制剂# #斑块型银屑病# #标准疗法#

Front Med：苏州大学儿童医院发表联合生物制剂与标准疗法治疗斑块型银屑病的疗效比较

2024-10-10发表于上海

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

J Clin Oncol：Brentuximab Vedotin联合AVD一线治疗早期不良霍奇金淋巴瘤的疗效优于标准疗法

2022-11-18

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤

2023-05-04

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Clin Cancer Res：帕博西尼+氟维司群联合方案或可成为晚期乳腺癌的标准疗法

2023-02-08

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后

2021-12-11

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Ibrance联合标准疗法治疗乳腺癌：未达到主要终点

2021-03-25

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

PACIFIC方案已是III期不可切除非小细胞肺癌的标准疗法

2019-10-31

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Gastroenterology：OTSC金属内镜夹治疗复发性上消化道出血效果优于标准疗法

2019-05-05

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Ann Oncol：依诺肝素联合标准疗法能否改善小细胞肺癌患者的总生存率？

2018-12-29

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

ANN ONCOL：CRLX101联合贝伐单抗与标准疗法比较治疗晚期肾细胞癌

2018-01-11

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Lancet Oncol：新辅助化疗联合辅助达拉菲尼和曲美替尼对比标准疗法治疗高危型、可手术切除的黑色素瘤的效果。

2018-02-25

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

ASCO：abiraterone与前列腺癌标准疗法联用，存活率可提高40%

2017-07-05

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

Neovii：临床研究长期结果有力支持Grafalon(R)成为标准疗法

2018-04-19

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

PNAS：维生素C或可增加AML标准疗法的疗效

2017-03-07

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

NEJM：新型银屑病药物的治疗效率优于当前标准疗法

2016-01-24

feather78 (审核中...)

前往app查看评论内容

#标准疗法#

JAMA：循证的标准疗法是降压治疗的关键

2014-01-29

科室
- - 订阅+
  - 更多科室
工具
服务